journal article·2022-04

Bacteria‐Targeting Photodynamic Nanoassemblies for Efficient Treatment of Multidrug‐Resistant Biofilm Infected Keratitis

Yiwen Zhu, Shijing Wu, Yujie Sun, Xuan Zou, Liang Zheng, Shun Duan, Julin Wang, Bingran Yu, Ruifang Sui, Fu‐Jian Xu

Advanced Functional Materials· Volume 32· Issue 14
Publisher page

Abstract

Abstract Multidrug‐resistant Pseudomonas aeruginosa (MDR‐P. aeruginosa) cannot be extirpated with any of the antipseudomonal antibiotics available in clinic because P. aeruginosa exhibit natural resistance to antibiotics and form a stable biofilm. Biofilm formed by P. aeruginosa is a leading cause of bacterial keratitis which may cause corneal perforation and even blindness. Antibacterial photodynamic therapy (aPDT) is a promising bactericidal method in combatting drug‐resistant bacteria. Unfortunately, the use of broad‐spectrum aPDT that kills bacteria indiscriminately may lead to microbiota imbalance and cause serious side effects in normal cells. Herein, PαGal50‐b‐PGRB20, which can effectively disperse biofilms and selectively kill MDR‐P. aeruginosa inside biofilms by binding to Lec A in the extracellular polymeric substances and on the P. aeruginosa membrane with low phototoxicity caused by broad‐spectrum aPDT, is designed and synthesized. PαGal50‐b‐PGRB20 has bactericidal activities by damaging DNA, RNA, protein, and membrane. In vivo study of the MDR‐P. aeruginosa biofilm infected keratitis model demonstrates the potential of PαGal50‐b‐PGRB20 for a better corneal recovery. This work provides a dedicated antibacterial material for preferentially killing MDR‐P. aeruginosa over normal cells and other bacteria.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ocular Infections and Treatments · Bacterial biofilms and quorum sensing · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chemical Resource Engineering Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education) and Laboratory of Biomedical Materials College of Materials Science and Engineering Beijing University of Chemical Technology Beijing 100029 China

Department of Ophthalmology State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100730 China

Laboratory of Electrochemical Process and Technology for Materials College of Materials Science and Engineering Beijing University of Chemical Technology Beijing 100029 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (47)

Show source-provided references
1. 10.1021/acsnano.7b0102310.1021/acsnano.7b01023 ↗
2. 10.1016/j.cej.2021.12846910.1016/j.cej.2021.128469 ↗
3. 10.1586/eop.13.710.1586/eop.13.7 ↗
4. 10.1038/ncomms546210.1038/ncomms5462 ↗
5. 10.1097/ICO.000000000000043110.1097/ICO.0000000000000431 ↗
6. 10.1002/smll.20200467710.1002/smll.202004677 ↗
7. 10.1038/eye.2012.21010.1038/eye.2012.210 ↗
8. 10.1097/ICL.0b013e318235c5af10.1097/ICL.0b013e318235c5af ↗
9. 10.1002/adfm.20180698610.1002/adfm.201806986 ↗
10. 10.1099/mic.0.27701-010.1099/mic.0.27701-0 ↗
11. 10.1002/anie.20170936810.1002/anie.201709368 ↗
12. 10.1021/jacs.7b1113310.1021/jacs.7b11133 ↗
13. 10.1039/C8NR05575K10.1039/C8NR05575K ↗
14. 10.1038/3502307910.1038/35023079 ↗
15. 10.1021/acs.nanolett.8b0100010.1021/acs.nanolett.8b01000 ↗
16. 10.1002/adma.20130262710.1002/adma.201302627 ↗
17. 10.1038/s41579-019-0158-910.1038/s41579-019-0158-9 ↗
18. 10.1021/acs.jmedchem.5b0169810.1021/acs.jmedchem.5b01698 ↗
19. 10.1016/j.chom.2019.02.00710.1016/j.chom.2019.02.007 ↗
20. 10.1111/j.1462-2920.2006.001001.x10.1111/j.1462-2920.2006.001001.x ↗
21. Kuhaudomlarp S. · Angew. Chem., Int. Ed. · 2020 · 60 · 2
22. 10.1021/acs.bioconjchem.8b0060010.1021/acs.bioconjchem.8b00600 ↗
23. 10.1111/j.1462-2920.2006.001001.x10.1111/j.1462-2920.2006.001001.x ↗
24. 10.1073/pnas.140263711110.1073/pnas.1402637111 ↗
25. 10.1021/jacs.9b1293610.1021/jacs.9b12936 ↗
26. 10.1038/s41467-021-20965-310.1038/s41467-021-20965-3 ↗
27. 10.1002/adfm.20170670910.1002/adfm.201706709 ↗
28. 10.1021/jacs.9b0716210.1021/jacs.9b07162 ↗
29. 10.1038/s41467-020-18268-010.1038/s41467-020-18268-0 ↗
30. 10.1038/s41587-019-0105-310.1038/s41587-019-0105-3 ↗
31. 10.1002/adma.20200677210.1002/adma.202006772 ↗
32. 10.1002/adma.20180602410.1002/adma.201806024 ↗
33. 10.1039/c3cs35504g10.1039/c3cs35504g ↗
34. 10.1039/C5SC03635F10.1039/C5SC03635F ↗
35. 10.1002/smll.20180020110.1002/smll.201800201 ↗
36. 10.1039/c3py00639e10.1039/c3py00639e ↗
37. Wu S. · Adv. Funct. Mater. · 2021 · 31
38. 10.1002/anie.20200050510.1002/anie.202000505 ↗
39. 10.1038/cddis.2011.13410.1038/cddis.2011.134 ↗
40. 10.1562/2006-04-14-IR-87410.1562/2006-04-14-IR-874 ↗
41. 10.1021/jacs.8b0501410.1021/jacs.8b05014 ↗
42. 10.1021/ja511079810.1021/ja5110798 ↗
43. 10.1002/advs.20200436910.1002/advs.202004369 ↗
44. 10.1038/s41564-019-0581-810.1038/s41564-019-0581-8 ↗
45. 10.1021/jacs.0c1077110.1021/jacs.0c10771 ↗
46. CLSI · 2018
47. 10.1021/acsabm.9b0012410.1021/acsabm.9b00124 ↗